TNF inhibitors and structural damage in ankylosing spondylitis
Crossref DOI link: https://doi.org/10.1038/nrrheum.2017.197
Published Online: 2017-12-07
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deodhar, Atul
Text and Data Mining valid from 2017-12-07
Article History
First Online: 7 December 2017
Competing interests
: A.D. declares that he has acted on the advisory board for or received research grants from Abbvie, Eli Lilly, Janssen, Novartis, Pfizer and UCB.